The endocannabinoid system in renal cells: Regulation of Na + transport by CB1 receptors through distinct cell signalling pathways

British Journal of Pharmacology

Volumn 172, Issue 19, 2015, Pages 4615-4625

  Sampaio, L S ^a,b,c   Taveira Da Silva, R ^a,b   Lima, D ^a,b   Sampaio, C L C ^a,b   Iannotti, F A ^d   Mazzarella, E ^d   Di Marzo, V ^d   Vieyra, A ^a,b,c   Reis, R A M ^a,e   Einicker Lamas, M ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagem   (Brazil)

^c MINISTRY OF EDUCATION OF BRAZIL   (Brazil)

^d CNR Consiglio Nazionale delle Ricerche   (Italy)

^e Lab Neuroquímica   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOCANNABINOID; HEMOPRESSIN; LIPID; MESSENGER RNA; PROTEIN KINASE C INHIBITOR; SODIUM ION; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; BENZOXAZINE DERIVATIVE; CYCLIC AMP; HEMOGLOBIN; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PEPTIDE FRAGMENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; SODIUM; VANILLOID RECEPTOR;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; ENZYME DEGRADATION; INCUBATION TIME; INTRACELLULAR SIGNALING; KIDNEY CELL; LLC PK1 CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SODIUM ABSORPTION; SODIUM TRANSPORT; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; KIDNEY; METABOLISM; PIG; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BENZOXAZINES; BIOLOGICAL TRANSPORT; CYCLIC AMP; ENDOCANNABINOIDS; HEMOGLOBINS; KIDNEY; LLC-PK1 CELLS; MORPHOLINES; NAPHTHALENES; PEPTIDE FRAGMENTS; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE; SWINE; TRPV CATION CHANNELS;

EID: 84940961736     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13050     Document Type: Article

References (42)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The concise guide to pharmacology 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013b). The concise guide to pharmacology 2013/14: ion channels. Br J Pharmacol 170: 1607-1651.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The concise guide to pharmacology 2013/14: transporters. Br J Pharmacol 170: 1706-1796.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013d). The concise guide to pharmacology 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
5. +-ATPase activity by WIN55,212-2 and delta(9)-THC. Eur J Pharmacol 572: 32-39.
6. Barutta F, Corbelli A, Mastrocola R, Gambino R, Di Marzo V, Pinach S, et al. (2010). Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. Diabetes 59: 1046-1054.
7. 1. Biochem J 312: 637-641.
8. i. Br J Pharmacol 137: 1380-1386.
9. +-ATPase. J Physiol 518: 37-46.
10. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, et al. (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265: 5267-5272.
11. De Mello FG, (1978). The ontogeny of dopamine-dependent increase of adenosine 3′,5′-cyclic monophosphate in the chick retina. J Neurochem 31: 1049-1053.
12. Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK, et al. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100: 1538-1546.
13. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC, (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613.
14. Di Marzo V, De Petrocellis L, (2012). Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc Lond B Biol Sci 367: 3216-3228.
15. Di Marzo V, Melck D, Bisogno T, De Petrocellis L, (1998). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21: 521-528.
16. + regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 278: 28719-28726.
17. Feizi A, Jafari MR, Hamedivafa F, Tabrizian P, Djahanguiri B, (2008). The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. Exp Toxicol Pathol 60: 405-410.
18. Gildea JJ, Wang X, Shah N, Tran H, Spinosa M, Van Sciver R, et al. (2012). Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension 60: 396-403.
19. 1 receptor. J Neurosci 17: 5327-5333.
20. Gomes I, Dale CS, Casten K, Geigner MA, Gozzo FC, Ferro ES, et al. (2010). Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J 12: 658-669.
21. Gomes P, Soares-da-Silva P, (2002). Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na(+)-K(+)-ATPase activity. Am J Physiol Renal Physiol 282: 1084-1096.
22. 1 cannabinoid receptors. Proc Natl Acad Sci U S A 104: 20588-20593.
23. Howlett AC, (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69: 619-631.
24. Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M, (1990). The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci 13: 420-423.
25. Iannotti FA, Piscitelli F, Martella A, Mazzarella E, Allarà M, Palmieri V, et al. (2013). Analysis of the 'endocannabinoidome' in peripheral tissues of obese Zucker rats. Prostaglandins Leukot Essent Fatty Acids 89: 127-135.
26. Jenkin KA, McAinch AJ, Grinfeld E, Hryciw DH, (2010). Role for cannabinoid receptors in human proximal tubular hypertrophy. Cell Physiol Biochem 26: 879-886.
27. Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM, (2006). Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 281: 32879-32890.
28. Kinoshita T, Takahashi I, Kobayashi E, Tamaoki T, Irie K, Koshimizu K, et al. (1990). Suppression by protein kinase C inhibitors of tumor promoter enhancement of Epstein-Barr virus-induced growth transformation. Anticancer Res 10: 1051-1054.
29. Koura Y, Ichihara A, Tada Y, Kaneshiro Y, Okada H, Temm CJ, et al. (2004). Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys. J Am Soc Nephrol 15: 1488-1494.
30. Laemmli UK, (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
31. Li J, Wang DH, (2006). Differential mechanisms mediating depressor and diuretic effects of anandamide. J Hypertens 24: 2271-2276.
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
33. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI, (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
34. Mukhopadhyay P, Pan H, Rajesh M, Bátkai S, Patel V, Harvey-White J, et al. (2010). CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br J Pharmacol 160: 657-668.
35. Patwardhan AM, Jeske NA, Price TJ, Gamper N, Akopian AN, Hargreaves KM, (2006). The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci USA 103: 11393-11398.
36. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res 42 (Database Issue): D1098-D1106.
37. +)-ATPase is a target for phosphoinositide 3-kinase/protein kinase B and protein kinase C pathways triggered by albumin. J Biol Chem 286: 45041-45047.
38. Schwartz IL, Shlatz LJ, Kinne-Saffran E, Kinne R, (1974). Target cell polarity and membrane phosphorylation in relation to the mechanism of action of antidiuretic hormone. Proc Natl Acad Sci USA 71: 2595-2599.
39. 1 receptor: structural insights. Biochemistry 49: 10449-10457.
40. Skorecki KL, Verkman AS, Ausiello DA, (1987). Cross talk between stimulatory and inhibitory guanosine 5′-triphosphate binding proteins: role in activation and desensitization of the adenylatecyclase response to vasopressin. Biochemistry 26: 639-645.
41. Taussky HH, Shorr E, (1953). A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202: 675-685.
42. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, et al. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457.